Chemours Co. Files 8-K: Material Agreement & Financial Obligations

Ticker: CC · Form: 8-K · Filed: 2024-11-29T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation, regulation-fd

Related Tickers: CC

TL;DR

Chemours signed a big deal and took on new financial obligations, filing an 8-K.

AI Summary

On November 29, 2024, The Chemours Company entered into a material definitive agreement. This filing also indicates the creation of a direct financial obligation or an off-balance sheet arrangement for the registrant. The report includes information related to Regulation FD Disclosure and Financial Statements and Exhibits.

Why It Matters

This filing signals a significant new agreement and potential financial commitments for Chemours, which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Material definitive agreements and new financial obligations can introduce financial risks and operational changes that warrant close monitoring.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by The Chemours Company?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.

What type of financial obligation has The Chemours Company created?

The filing states the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specifics are not detailed in the provided text.

What is the filing date for this 8-K report?

The filing date for this 8-K report is November 29, 2024.

What is the principal executive office address for The Chemours Company?

The address of the principal executive offices for The Chemours Company is 1007 Market Street, Wilmington, Delaware 19801.

What is the IRS Employer Identification Number for The Chemours Company?

The IRS Employer Identification Number for The Chemours Company is 46-4845564.

From the Filing

0000950170-24-131910.txt : 20241129 0000950170-24-131910.hdr.sgml : 20241129 20241129163630 ACCESSION NUMBER: 0000950170-24-131910 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241129 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241129 DATE AS OF CHANGE: 20241129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 241516667 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20241129.htm 8-K 8-K false 0001627223 0001627223 2024-11-29 2024-11-29     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   November 29, 2024 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐           Item 1.01 Entry into a Material Definitive Agreement. On November 29, 2024, The Chemours Company (the “Company”) entered into Amendment No. 1 (the “Amendment”) among the Company, certain subsidiaries of the Company, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), which amends the Second Amended and Restated Credit Agreement, dated as of August 18, 2023, among the Company, the lenders from time to time party thereto a

View on Read The Filing